Ozmosi | Acupuncture Drug Profile
Drug Search Results
Using advanced filters...
Advanced Search [+]

Acupuncture

Alternative Names: Acupuncture
Clinical Status: Inactive
Latest Update: 2026-03-10
Latest Update Note: Clinical Trial Update

Product Description

Acupuncture in the treatment of acute toxicity during and after head and neck cancer radiotherapy; In this interim analysis, acupuncture leads to lower pain andfaster disappearance of skin and mucosal toxicity after (chemo)radiotherapy of head and neck cancer. (Sourced from: https://pubmed.ncbi.nlm.nih.gov/32597419/)

Mechanisms of Action: No Mechanism

Novel Mechanism: No

Modality: Unknown

Route of Administration: N/A

FDA Designation: *

Approval Status: Not Approved

Approved Countries: Australia

Approved Indications: None

Known Adverse Events: None

Company: University of Traditional Chinese Medicine
Company Location:
Company Founding Year: None
Additional Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Acupuncture

Countries in Clinic: China, Taiwan, United States

Active Clinical Trial Count: 3

Recent & Upcoming Milestones

Highest Development Phases

Phase 2: Breast Cancer|Breast Diseases|Dyslipidemia|Obesity|Peripheral Nervous System Diseases|Urinary Retention

Trial ID

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Latest Trial Update Date

Data Updated

NCT05458284

NCT05458284

P2

Active, not recruiting

Breast Diseases|Peripheral Nervous System Diseases|Breast Cancer

2026-07-01

2025-08-29

Primary Completion Date|Primary Endpoints

NCT06703788

MOHW113-CMAP-M-113-000003-B

P2

Recruiting

Obesity|Dyslipidemia

2025-06-01

2024-11-27

Primary Endpoints|Treatments

NCT05898919

HCDUTCM_2022056

P2

Completed

Urinary Retention

2023-05-25

2023-07-11